{
    "laboratory_examinations": [
        {
            "procedure_name": "Continuous Glucose Monitoring (CGM)",
            "date": "April 2016",
            "findings": "Severe hypoglycemia occurred (sensor glucose â‰¤50 mg/dL) during therapy with pasireotide.",
            "changes_over_time": "Severe hypoglycemia occurred only during Period C of pasireotide therapy after previously being controlled with DZX."
        },
        {
            "procedure_name": "Instrumental Workup (includes MRI, CT, and Scintigraphy)",
            "date": "December 2017",
            "findings": "An 8.0-mm benign insulinoma relapse was identified, characterized as Ki-67 = 1%, WHO grading = G1.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Hemoglobin A1c",
            "date": "6- and 9-month follow-up after surgery",
            "findings": "Altered glucose regulation within the prediabetes range (hemoglobin A1c = 41 mmol/mol).",
            "changes_over_time": "A progressive increase in prediabetes range was detected at the follow-up visits."
        }
    ]
}